Original article
Vol. 5 Núm. 3 (English)
45 min
Cómo citar
Métricas
24
Visualizaciones
Compartir
Compartir
Resumen (EN)
Palabras clave (EN):
Resumen (ES)
Palabras clave (ES):
Benign acute childhood myositis (BACM) is a usually self-limited condition affecting preschool- and school-aged children, generally associated with viral infections. It is characterized by a transient inflammatory process involving the muscles and a benign course1.
Its incidence and prevalence have not been precisely established, although it is reported more frequently during periods of seasonal virus circulation, with an estimated 0.23 to 2.6 cases per 100,000 children under 18 years of age2,3. Several authors have reported associations with Influenza B4 and other infectious agents, such as Influenza A, Parainfluenza, Adenovirus, Coxsackie virus, SARS-CoV-2, and Mycoplasma pneumoniae5,6,7.
The etiopathogenic mechanisms have not yet been fully elucidated. It has been postulated that muscle damage may be attributable both to immune-mediated responses and to direct viral invasion of muscle tissue, triggering reversible injury to muscle fibers1,8.
Rhabdomyolysis is described as a serious complication which, although uncommon, can lead to secondary renal dysfunction or injury8,9. Currently, evidence on the course of rhabdomyolysis and the degree of renal involvement in this context is limited.
The characteristic clinical presentation consists of symmetric muscle pain in the lower extremities and variable functional impairment, preceded or accompanied by upper respiratory symptoms and fever10.
Muscle pain has an acute onset and predominantly affects the calves symmetrically. It is associated with elevated serum creatine phosphokinase (CPK) levels; other muscle enzymes, such as aldolase, lactate dehydrogenase (LDH), and aspartate aminotransferase (AST/GOT), may also be elevated. Traditionally, CPK has been the reference serum biomarker for diagnosing and monitoring myositis because of its high sensitivity for detecting muscle damage10.
Myoglobinuria reflects the massive release of muscle components into the bloodstream secondary to acute myolysis, potentially predisposing to the development of acute kidney injury through renal vasoconstriction, direct tubular cytotoxicity, and obstruction caused by the formation of intramedullary casts3.
The clinical course is usually self-limited within 7 to 10 days of symptom onset.2
The aim of this study is to describe the epidemiological characteristics, diagnostic and therapeutic strategies, and clinical course of a cohort of patients diagnosed with BACM.
An observational retrospective study was conducted in the emergency department (ED) of a tertiary care university pediatric hospital, which sees approximately 120,000 visits annually for acute conditions.
Patients aged 2 to 16 years with a discharge diagnosis of myositis recorded in the electronic health records (EHRs) between January 2013 and December 2022 were included. Patients with chronic diseases or conditions that could explain elevated CPK levels, myoglobinuria, or kidney injury (for example, trauma; rheumatologic, neuromuscular, oncologic, endocrine, metabolic, nephro-urologic, or cardiomyopathic conditions; or use of myotoxic drugs) were excluded, as were those with alternative discharge diagnoses (such as sepsis, osteomyelitis, cellulitis, abscesses, or myositis ossificans).
Data were collected through a systematic review of the EHRs. Demographic variables, clinical manifestations, laboratory tests, virological findings in nasopharyngeal secretions (NPS), and clinical course variables, such as length of hospital stay and the need for admission to the pediatric intensive care unit (PICU), were analyzed.
Myositis was defined as the presence of acute-onset, intense muscle pain predominantly and symmetrically affecting the lower limbs and/or functional impairment secondary to pain, associated with elevated serum CPK levels. Functional impairment was defined as the transient loss or limitation of the previously acquired ability to walk.
Renal function impairment was defined as the presence of elevated serum creatinine levels for age.
Given the retrospective nature of the study, laboratory test results were obtained from the EHRs and corresponded to tests performed by the institutional laboratory as part of the patients’ routine care.
CPK measurements were performed using the kinetic ultraviolet spectrophotometric method, following the recommendations of the International Federation of Clinical Chemistry and Laboratory Medicine (IFCC), and serum creatinine measurements were performed using the kinetic colorimetric Jaffé method with blank compensation, traceable to isotope dilution mass spectrometry.
The results were interpreted according to the age- and sex-specific reference values established by the hospital laboratory.
Direct testing for myoglobinuria is not part of the institution’s standard protocol. Therefore, its presence was inferred indirectly from a positive urine dipstick test for blood pigments (detection of the pseudoperoxidase activity of the heme group) in the absence of significant numbers of red blood cells in the urinary sediment, in a clinical context consistent with rhabdomyolysis or muscle injury11.
Categorical variables were expressed as absolute frequencies and percentages. For quantitative variables, the median was used as the measure of central tendency and the interquartile range (IQR) as the measure of dispersion. Categorical variables were compared using the Chi2 test, whereas quantitative variables were analyzed using the nonparametric Mann-Whitney U test. Statistical significance was set at p < 0.05. Analyses were performed using the statistical software packages STATA 14 and SPSS version 26.
The study was approved by the Review and Research Ethics Committee of the Associate Directorate of Teaching and Research.
A total of 184 medical records were reviewed for the period between January 1, 2013, and December 31, 2022. Of these, 163 patients met the diagnostic criteria for myositis; 87 were excluded, leaving a sample of 76 patients for analysis (Figure 1). The median age was 7 years (IQR 6–9). Males accounted for 73.7% (56/76).
The reasons for seeking care were bilateral lower-limb pain (79%, 60/76), functional impairment (17%, 13/76), and gait disturbance (4%, 3/76). Pain was predominantly localized to the calf muscles (50/60).
Among the associated symptoms, fever and respiratory symptoms were the most frequent findings, at 84% (64/76) and 83% (63/76), respectively. Most respiratory symptoms (60/63) involved the upper respiratory tract.
Among the additional tests performed, blood tests (complete blood count, urea, creatinine, and CPK), urinalysis, and virologic testing of nasopharyngeal secretions were documented in the EHR in 100%, 37%, and 51% of cases, respectively.
The median CPK level recorded on admission was 1,817 IU/L (IQR: 924.75–3,874.75).
Only one patient, a 10-year-old, had elevated serum creatinine (0.89 mg/dL). On admission, the CPK level was 4,427 IU/L, urinalysis was normal, and Influenza B virus was detected in the nasopharyngeal secretion (NPS) sample. The patient remained hospitalized for four days, with a progressive decrease in CPK and creatinine levels until they normalized on the sixth day after the initial consultation.
Urine findings suggestive of myoglobinuria were observed in a single patient. At admission, the CPK level was 25,721 IU/L, while serum creatinine and urea concentrations were within the reference ranges.
No significant differences in CPK levels were found according to sex (female: median 1,993 IU/L [IQR 1,246-4,332] vs. male: median 1,536 IU/L [IQR 911-3,786], p = 0.28), presence of fever (no fever: median 2,156 IU/L [IQR 1,101-5,589] vs. fever: median 1,817 IU/L [IQR 911-3,808], p = 0.41), or the result of the virological testing of NPS (positive: median 3,800 IU/L [IQR 1,597-5,174] vs. negative: median 3,447 IU/L [IQR 1,396-6,788], p = 0.86).
The microbiological results obtained from NPS are described in Figure 2.
NPS: nasopharyngeal secretions.
Among patients discharged with a diagnosis of myositis, more than half (60%) were hospitalized for pain management and parenteral hydration. The median length of hospital stay was 2 days [IQR 2–3]. No patients required transfer to the PICU.
BACM is most frequently described in preschool- and school-aged children and adolescents, with a documented peak incidence between 4 and 11 years of age2,8,12. In children under 2 years of age, its clinical interpretation is often more challenging, which is why they were not included in this study.
Consistent with the findings reported by Cardin et al.8 and Cavagnaro et al.2, most patients with BACM in this study presented with pain and functional impairment of the lower limbs. Likewise, most patients had fever and respiratory symptoms2,8.
Although the diagnosis of this condition is primarily clinical, elevated serum CPK concentrations constitute a biochemical criterion that contributes to diagnostic suspicion. CPK concentrations up to 20 to 30 times the upper reference limit have been reported and may remain elevated for up to 2 weeks1,2,8; however, they are not usually accompanied by myoglobinuria or kidney injury1,13,14. In this cohort, only one patient had findings suggestive of myoglobinuria, with a peak CPK level of 37,283 IU/L during the hospital stay, but no evidence of impaired renal function.
As reported in the publication by Delavar et al.14, no clinically significant impairment of renal function was observed in patients in this cohort. Only one patient initially presented with a transient elevation in serum creatinine (0.89 mg/dL; age-specific reference range: 0.39–0.73 mg/dL), with an unremarkable urinalysis; levels returned to normal within 24 hours after intravenous hydration.
Although rhabdomyolysis and acute kidney injury have been reported in patients with BACM, they appear to be uncommon1,2,3,4,6,7,8,10,12,13,15.
Along the same lines, although BACM has a benign course, it leads to hospitalization in many affected patients. The findings of this study could contribute to discussions about the rational use of resources in patients with suspected BACM. For example, none of the results of the complete blood counts ordered justified therapeutic intervention; virtually no patients had significant renal involvement and, although screening for it was performed in only slightly more than one third of patients, findings suggestive of myoglobinuria were detected in only one child, who had markedly elevated serum CPK levels. In this context, the indications for hospitalization in these patients could also be reconsidered when they are well hydrated, tolerate and are willing to take oral fluids, and have adequate pain control with oral analgesics.
This study has several strengths. It provides regional information on a condition that is relatively uncommon and has been little studied in Latin America. It includes a cohort collected over a prolonged period of ten years at a high-complexity pediatric hospital with university affiliation and a high volume of consultations, allowing the clinical and biochemical characteristics of patients with BACM treated in the ED to be consistently described. Strict exclusion criteria were applied to minimize the inclusion of alternative causes of elevated serum CPK levels and renal impairment. Finally, the study specifically examines the presence of renal abnormalities and myoglobinuria, aspects that are relevant to clinical decision-making in the ED.
Nevertheless, the study has limitations. Its retrospective design carries an inherent risk of information bias related to the quality of the EHR records. The diagnostic and therapeutic approach was not protocolized; therefore, the ordering of additional tests and clinical and biochemical follow-up were left to the discretion of the treating medical team. Consequently, not all patients underwent systematic assessment of urinalysis, renal function, and serial serum CPK measurements. In addition, the indirect definition of myoglobinuria based on suggestive findings may reduce the diagnostic accuracy for this event.
Furthermore, the limited sample size reduces the statistical power to detect rare events, such as severe complications associated with rhabdomyolysis or acute kidney injury, thereby limiting the precision of the estimates.
The possibility of selection bias should also be considered, as only patients discharged with a diagnosis of myositis were included, potentially excluding mild cases or presentations coded under other diagnoses.
Regarding the viral testing of nasopharyngeal secretions, diagnostic methods varied, which could have influenced the results.
No systematic post-discharge follow-up was recorded to detect, for example, possible recurrences or sequelae.
Finally, because this was a single-center study conducted at a tertiary care hospital, the findings should be extrapolated to other care settings with caution.
In this cohort of pediatric patients with BACM seen in the ED, no cases of clinically significant kidney injury were observed. These findings support the typically benign, self-limiting nature of the condition.
Studies with greater methodological rigor are needed to identify factors associated with complications and optimize management strategies for patients with BACM.
Explorar
Artículos
Volúmenes
Sobre la revista
Más leídos
Emergencias Pediátricas
Emergencias Pediátricas
Emergencias Pediátricas
Emergencias Pediátricas
Emergencias Pediátricas